TAKEDA PHARMACEUTICAL CO LTD (TAK)

NYSE Pharmaceutical Pharmaceutical Preparations SIC: 2834
B
Pipeline Grade

Drug Pipeline (1 Assets)

DrugPhaseIndications
CEFOTIAM HYDROCHLORIDE
CERADON 		NDA Adjuvant Chemotherapy, Anticoagulant-induced Bleeding, Brain Disorder, Cardiovascular Diseases, Central Nervous System Diseases, Cerebral Hemorrhage, Cerebral Vascular Disorder, Colorectal Cancer, ctDNA, Diabetes, Fruquintinib, Hemorrhage, Hypertension, Intracranial Hemorrhages, Minimal Residual Disease, Stroke, Tislelizumab

Upcoming Catalysts

No upcoming catalysts detected for this company.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for TAK.

SEC EDGAR Filings

All SEC filings for TAKEDA PHARMACEUTICAL CO LTD on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.